Volume 14, Number 11—November 2008
Research
Multidrug- and Extensively Drug-Resistant Tuberculosis, Germany
Table 3
Treatment outcomes | No. (%) patients not treated previously, n = 84 | No. (%) patients treated previously, n = 100 | p value | 95% CI |
---|---|---|---|---|
Cured | 40 (47.6) | 42 (42) | 0.49 | −0.09 to 0.19 |
Completed | 8 (9.5) | 19 (19) | 0.05 | −0.19 to −0.001 |
Successful treatment (cured + completed) | 48 (57) | 61 (61) | 0.58 | −0.18 to 0.1 |
Died | 7 (8.3) | 8 (8) | 1 | −0.07 to 0.07 |
Failure | 1 (1.19) | – | – | – |
Treatment failure (death or failure) | 8 (9) | 8 (8) | 0.8 | −0.07 to 0.09 |
Default | – | 1 (1) | – | – |
Transferred out | 13 (15.5) | 12 (12) | 0.55 | −0.06 to 0.12 |
Uncertain outcome (default + transferred out) | 13 (15.5) | 13 (13) | 0.69 | −0.08 to 0.12 |
Still receiving treatment |
15 (17.9) |
18 (18) |
0.85 |
−0.12 to 0.1 |
*TB, tuberculosis; CI, confidence interval. |
1Additional German Tuberculosis Network European Trials group (TBNET) contributors: R. Eberhardt, Thorax-Clinic-Heidelberg, Heidelberg; A. Esselmann, Pulmonary Clinic, Hemer; H. Flick, Charité, Berlin; M. Hamm, Hospital Diekholzen, Diekholzen; P. Hammerl, Hospital Immenhausen, Immenhausen; H. Hang, Hospital Schillerhöhe, Schillerhöhe; P. Hannemann, Deakoness Hospital, Neustadt; D. Hillemann, Research Center Borstel, Borstel; B. Kretz, Asklepios Hospital, Gauting; C. Laumanns, Bethania Hospital, Solingen; G. Liebetrau, Lostau Hospital, Lostau; S. Ott, Helios Clinic Emil von Behring, Berlin; A. Paulick, Pulmonary Clinic-Coswig, Coswig; M.W. Pletz, Hannover Medical School, Hannover; M. Rau, Pulmonary Clinic, Wangen; G. Rohde, Bergmannsheil Hospital, Bochum; A. de Roux, Evangelische Lungenklinik, Berlin; C. Schaudt, Hospital St. Blasien, St. Blasien; K-D.Schneider, Pulmonary Clinic, Hannover-East, Hannover; S. Stenger, University Hospital, Ulm; D. Wagner, University Hospital, Freiburg; and T. Wolf, University Hospital, Frankfurt.